Financial Network Wealth Management LLC Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Financial Network Wealth Management LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 14.5% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,649 shares of the healthcare conglomerate’s stock after selling 451 shares during the quarter. Financial Network Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,340,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter worth $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter valued at $30,000. Promus Capital LLC bought a new position in UnitedHealth Group during the fourth quarter valued at $32,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the third quarter valued at $37,000. Finally, Pillar Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $40,000. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

UNH stock opened at $512.30 on Friday. The firm has a market cap of $468.61 billion, a price-to-earnings ratio of 33.05, a PEG ratio of 1.37 and a beta of 0.62. The firm has a 50-day simple moving average of $510.24 and a two-hundred day simple moving average of $547.97. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same period last year, the firm posted $5.83 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Stephens upped their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.